The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis show enhanced formation of aggregates in vitro
Open accessAbstract
Mutations in Cu/Zn superoxide dismutase (SOD) are associated with the fatal neurodegenerative disorder amyotrophic lateral sclerosis (ALS). There is considerable evidence that mutant SOD has a gain of toxic function; however, the mechanism of this toxicity is not known. We report here that purified SOD forms aggregates in vitro under destabilizing solution conditions by a process involving a transition from small amorphous species to fibrils. The assembly process and the tinctorial and structural properties of the in vitro aggregates resemble those for aggregates observed in vivo . Furthermore, the familial ALS SOD mutations A4V, G93A, G93R, and E100G decrease protein stability, which correlates with an increase in the propensity of the mutants to form aggregates. These mutations also increase the rate of protein unfolding. Our results suggest three possible mechanisms for the increase in aggregation: ( i ) an increase in the equilibrium population of unfolded or of partially unfolded states, ( ii ) an increase in the rate of unfolding, and ( iii ) a decrease in the rate of folding. Our data support the hypothesis that the gain of toxic function for many different familial ALS-associated mutant SODs is a consequence of protein destabilization, which leads to an increase in the formation of cytotoxic protein aggregates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McCord, J. M., & Fridovich, I. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63504-5 · Cited by 12,952
MARKLUND, S., & MARKLUND, G. (1974) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1974.tb03714.x · Cited by 10,354
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434
Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding
Fersht, A. (2017) · Series in Structural Biology · doi:10.1142/10574 · Cited by 2,039
Rowland, L. P., & Shneider, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442207 · Cited by 1,812
From charcot to lou gehrig: deciphering selective motor neuron death in als
Cleveland, D. W., & Rothstein, J. D. (2001) · Nature Reviews Neuroscience · doi:10.1038/35097565 · Cited by 1,389
[18] Quantification of β-sheet amyloid fibril structures with thioflavin T
LeVine, H. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)09020-5 · Cited by 1,365
Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
Booth, D. R., Sunde, M., Bellotti, V., Robinson, C. V., Hutchinson, W. L., Fraser, P. E., Hawkins, P. N., Dobson, C. M., Radford, S. E., Blake, C. C. F., et al. (1997) · Nature · doi:10.1038/385787a0 · Cited by 1,048
Johnston, J. A., Dalton, M. J., Gurney, M. E., & Kopito, R. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220417997 · Cited by 607
Kirkitadze, M. D., Bitan, G., & Teplow, D. B. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10328 · Cited by 585
Fridovich, I. (1986) · Advances in Enzymology - and Related Areas of Molecular Biology · doi:10.1002/9780470123041.ch2 · Cited by 468
Julien, J.-P. (2001) · Cell · doi:10.1016/s0092-8674(01)00244-6 · Cited by 434
Faster superoxide dismutase mutants designed by enhancing electrostatic guidance
Getzoff, E. D., Cabelli, D. E., Fisher, C. L., Parge, H. E., Viezzoli, M. S., Banci, L., & Hallewell, R. A. (1992) · Nature · doi:10.1038/358347a0 · Cited by 399
Self-citationSequence-dependent denaturation energetics: A major determinant in amyloid disease diversity
Hammarström, P., Jiang, X., Hurshman, A. R., Powers, E. T., & Kelly, J. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202495199 · Cited by 359
[19] Quantifying amyloid by congo red spectral shift assay
Klunk, W. E., Jacob, R. F., & Mason, R. P. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)09021-7 · Cited by 351
Protein misfolding and disease; protein refolding and therapy
Soto, C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02486-3 · Cited by 336
Khurana, R., Gillespie, J. R., Talapatra, A., Minert, L. J., Ionescu-Zanetti, C., Millett, I., & Fink, A. L. (2001) · Biochemistry · doi:10.1021/bi001782b · Cited by 325
Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase.
Parge, H. E., Hallewell, R. A., & Tainer, J. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.6109 · Cited by 304
Self-citationBruening, W., Roy, J., Giasson, B., Figlewicz, D. A., Mushynski, W. E., & Durham, H. D. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720693.x · Cited by 263
Amyotrophic lateral sclerosis: A proposed mechanism
Okado-Matsumoto, A., & Fridovich, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132260399 · Cited by 247
Rodriguez, J. A., Valentine, J. S., Eggers, D. K., Roe, J. A., Tiwari, A., Brown, R. H., & Hayward, L. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112088200 · Cited by 238
Okamoto, K., Hirai, S., Yamazaki, T., Sun, X., & Nakazato, Y. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90469-a · Cited by 226
Shinder, G. A., Lacourse, M.-C., Minotti, S., & Durham, H. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010759200 · Cited by 202
Lindberg, M. J., Tibell, L., & Oliveberg, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262527099 · Cited by 193
Kato, S., Takikawa, M., Nakashima, K., Hirano, A., Cleveland, D. W., Kusaka, H., Shibata, N., Kato, M., Nakano, I., & Ohama, E. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515160 · Cited by 180
Ratovitski, T., Corson, L. B., Strain, J., Wong, P., Cleveland, D. W., Culotta, V. C., & Borchelt, D. R. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.8.1451 · Cited by 180
NONAMYLOIDOTIC MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE
Buxbaum, J., & Gallo, G. (1999) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70123-4 · Cited by 174
Ascorbate Autoxidation in the Presence of Iron and Copper Chelates
Buettner, G. R., & Czapski, P. G. (1986) · Free Radical Research Communications · doi:10.3109/10715768609051638 · Cited by 171
Goto, J. J., Zhu, H., Sanchez, R. J., Nersissian, A., Gralla, E. B., Valentine, J. S., & Cabelli, D. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1007 · Cited by 166
Lepock, J. R., Frey, H. E., & Hallewell, R. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45784-5 · Cited by 139
Self-citationProtein Misfolding and Disease
Bross, P., & Gregersen, N. (2003) · Humana Press eBooks · doi:10.1385/1592593941 · Cited by 130
Domain Stability in Immunoglobulin Light Chain Deposition Disorders
Wetzel, R. B. (1997) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60322-8 · Cited by 107
Amyotrophic lateral sclerosis: copper/zinc superoxide dismutase (SOD1) gene mutations
Orrell, R. W. (2000) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00071-1 · Cited by 91
Cardoso, R. M. F., THAYER, M. M., DiDonato, M., Lo, T. P., Bruns, C. K., Getzoff, E. D., & Tainer, J. A. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01090-2 · Cited by 81
Stieber, A., Gonatas, J. O., & Gonatas, N. K. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00300-7 · Cited by 76
Evolutionary Aspects of Superoxide Dismutase: The Copper/Zinc Enzyme
BANNISTER, W. H., Bannister, J. V., Barra, D., Bond, J. M., & Bossa, F. (1991) · Free Radical Research Communications · doi:10.3109/10715769109145804 · Cited by 63
Chrunyk, B. A., & Wetzel, R. B. (1993) · Protein Engineering Design and Selection · doi:10.1093/protein/6.7.733 · Cited by 40
Superoxide dismutase-1 mutation-related neurotoxicity in familial amyotrophic lateral sclerosis
Shibata, N., Hirano, A., Yamamoto, T., Kato, Y., & Kobayashi, M. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515151 · Cited by 34
Cited by
Cellular strategies for controlling protein aggregation
Tyedmers, J., Mogk, A., & Bukau, B. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2993 · Cited by 896
Amyloid formation by globular proteins under native conditions
Chiti, F., & Dobson, C. M. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.131 · Cited by 812
COPPER-ZINC SUPEROXIDE DISMUTASE AND AMYOTROPHIC LATERAL SCLEROSIS
Valentine, J. S., Doucette, P. A., & Zittin Potter, S. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161647 · Cited by 785
The genetic epidemiology of neurodegenerative disease
Bertram, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24761 · Cited by 680
Pawar, A. P., DuBay, K. F., Zurdo, J., Chiti, F., Vendruscolo, M., & Dobson, C. M. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.04.016 · Cited by 588
Metadata
- Authors
- Stathopulos, P. B., Rumfeldt, J. A. O., Scholz, G. A., Irani, R. A., Frey, H. E., Hallewell, R. A., Lepock, J. R., & Meiering, E. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-05-28
- Volume
- 100
- Issue
- 12
- Pages
- 7021-7026
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2112761293
- Cited by
- 258
- References
- 39
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.